Manufacturer: Focus Biomolecules
Binimetinib (606143-89-9) is a potent (IC50 = 12 nM) and selective allosteric inhibitor of MEK1/2.1,2 Recently approved by the FDA for treatment of melanoma in combination with Encorafenib. Binimetinib has had limited success as monotherapy but has shown promise in combination with other chemotherapeutic agents.3-5
CAS Number: 606143-89-9
Manufacturer Part Number/SKU: 10-4789-25mg-EA
Tags: Focus Biomolecules